Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Berrak, Özge"'
Publikováno v:
In Materials Science & Engineering C 1 October 2018 91:382-388
Autor:
Berrak, Özge, Akkoç, Yunus, Arısan, Elif Damla, Çoker-Gürkan, Ajda, Obakan-Yerlikaya, Pınar, Palavan-Ünsal, Narçin
Publikováno v:
In Biomedicine & Pharmacotherapy February 2016 77:150-160
Autor:
Akkoç, Yunus, Berrak, Özge, Arısan, Elif Damla, Obakan, Pınar, Çoker-Gürkan, Ajda, Palavan-Ünsal, Narçin
Publikováno v:
In Biomedicine & Pharmacotherapy April 2015 71:161-171
Autor:
OBAKAN, PINAR, YILDIRIM, ŞEYMA, ÖZTÜRK, MERT BURAK, BERRAK, ÖZGE, GÜRKAN, AJDA ÇOKER, ARISAN, ELİF DAMLA, ÜNSAL, ZEYNEP NARÇİN
Publikováno v:
Volume: 39, Issue: 5 712-721
Turkish Journal of Biology
Turkish Journal of Biology
The cyclin-dependent kinase (CDK) inhibitors purvalanol and roscovitine are therapeutic agents that control cell proliferation through regulating cell-cycle machinery. They also affect polyamine (PA) metabolism, which is activated in malignant tissue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=tubitakulakb::0bac0b96d9cf260816930a2449582d80
https://dergipark.org.tr/tr/pub/tbtkbiology/issue/11766/140621
https://dergipark.org.tr/tr/pub/tbtkbiology/issue/11766/140621
Autor:
Gümüşkaptan, Çağrı, Berrak, Özge, Obakan Yerlikaya, Pınar, Çoker Gürkan, Ajda, Ünsal, Zeynep Narçin, ARISAN, ELİF DAMLA
Cyclin dependent kinases (CDKs) are known activators of nuclear hormone receptors; such as androgen receptor (AR) via modulating several cell survival signaling routes. However, novel CDK inhibitors might also prevent cell proliferation and induce ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3400::c39aa1c167938ec3634ec696b0210e4e
https://doi.org/10.4172/1948-5956.S1.044
https://doi.org/10.4172/1948-5956.S1.044
Autor:
Obakan Yerlikaya, Pınar, Yıldırım, Şeyma, Öztürk, Mert Burak, Berrak, Özge, Çoker Gürkan, Ajda, Ünsal Palavan, Zeynep Narçın, ARISAN, ELİF DAMLA
The cyclin-dependent kinase (CDK) inhibitors purvalanol and roscovitine are therapeutic agents that control cell proliferation through regulating cell-cycle machinery. They also affect polyamine (PA) metabolism, which is activated in malignant tissue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3400::abe2f251b4b0a95be7f7ff719629d6c3
https://doi.org/10.3906/biy-1501-18
https://doi.org/10.3906/biy-1501-18